Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/731766/000073176622000044/unh-20220930.htm
May 2024
April 2024
March 2024
March 2024
February 2024
February 2024
February 2024
January 2024
December 2023
November 2023
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/731766/000073176622000044/unh-20220930.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by UnitedHealth Group Inc.
UnitedHealth Group Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More
LIQUIDITY, FINANCIAL CONDITION AND CAPITAL RESOURCES Liquidity Summary of our Major Sources and Uses of Cash and Cash Equivalents 2022 Cash Flows Compared to 2021 Cash Flows Increased cash flows provided by operating activities were primarily driven by an increase in unearned revenue due to the September receipt of our October CMS premium payment of $9.8 billion and increased net earnings.
In June 2022, the Company's Board of Directors increased our quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share.
21 Table of Contents Optum Insight Revenues and earnings from operations at Optum Insight increased due to growth in technology and managed services, with managed services growth driven by higher payer volumes and new health system partnerships.
Optum Rx Revenues and earnings from operations at Optum Rx increased due to higher script volumes from growth in people served, increased utilization and organic growth in pharmacy care services, including community-behavioral and specialty pharmacy.
Earnings from operations also increased as a result of continued supply chain management initiatives.
Optum Total revenues and earnings...Read more
The rate of market growth...Read more
As of September 30, 2022,...Read more
Given the significant portion of...Read more
Consolidated earnings from operations of...Read more
We utilize various metrics to...Read more
Consolidated revenues grew 12%, UnitedHealthcare...Read more
UnitedHealthcare's revenues increased due to...Read more
A significant downgrade in our...Read more
For the three months ended...Read more
The metrics also allow management...Read more
2022 RESULTS OF OPERATIONS COMPARED...Read more
We continually evaluate opportunities to...Read more
The results by segment were...Read more
We will continue seeking to...Read more
For the three months ended...Read more
Future developments, such as the...Read more
Other significant changes in sources...Read more
Our two distinct, yet complementary...Read more
As of that date, the...Read more
Financial Condition As of September...Read more
For more information on our...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
UnitedHealth Group Inc provided additional information to their SEC Filing as exhibits
Ticker: UNH
CIK: 731766
Form Type: 10-Q Quarterly Report
Accession Number: 0000731766-22-000044
Submitted to the SEC: Wed Nov 02 2022 4:08:29 PM EST
Accepted by the SEC: Wed Nov 02 2022
Period: Friday, September 30, 2022
Industry: Hospital And Medical Service Plans